Press "Enter" to skip to content

FDA approves new treatment for refractory multiple myeloma

FDA grants accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is resistant to several other form

Original source: http://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-refractory-multiple-myeloma

Also Read:   UPDATE: Reduce the Risk of Cardiac Surgery Infection While Using the LivaNova Heater-Cooler System 3T: FDA Safety Communication